AL
LEG icon

Aspiriant LLC’s Leggett & Platt LEG Stock Holding History

Aspiriant LLC’s Portfolio LEG Stock Details LEG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,561
Closed -$230K – 222
2017
Q1 		$230K Buy
+4,561
New +$223K 0.02% 192

Other funds holding LEG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T
Thomaspartners Boston, Massachusetts $13.7B AUM 8.42% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Aspiriant LLC's LEG Position: Q2 2017 in Review

Aspiriant LLC sold out of Leggett & Platt (LEG) in Q2 2017, closing a stake of 4,561 shares — an estimated $230K sold.

Aspiriant LLC first reported a position in LEG in Q1 2017 and held it in 1 quarter. The position peaked at $230K in Q1 2017. 495 funds tracked by Wall St. Rank hold LEG as of Q2 2017.

  • Aspiriant LLC reported no remaining Leggett & Platt position as of Q2 2017 after selling out during the quarter.
  • Aspiriant LLC sold 4,561 Leggett & Platt shares in Q2 2017, an estimated $230K.
  • Aspiriant LLC first reported a position in Leggett & Platt in Q1 2017 and held it in 1 quarter.
  • Aspiriant LLC's Leggett & Platt position peaked at $230K in Q1 2017.
  • 495 funds tracked by Wall St. Rank held Leggett & Platt as of Q2 2017.

Based on Aspiriant LLC's 13F filing for Q2 2017, filed 3 Aug 2017.